HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Vivek Rao Michael A. Borger Richard D. Weisel George T. Christakis Gideon Cohen Terrence M. Yau Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rao, V. Articles by Yau, T. M. Search for Related Content PubMed PubMed Citation Articles by Rao, V. Articles by Yau, T. M.

J Thorac Cardiovasc Surg 2000;119:1176-1184
© 2000 The American Association for Thoracic Surgery

SURGERY FOR ACQUIRED CARDIOVASCULAR DISEASE

INSULIN CARDIOPLEGIA FOR ELECTIVE CORONARY BYPASS SURGERY

From The Toronto General Hospital and Sunnybrook Health Science Centre at The University of Toronto, Toronto, Ontario, Canada.

Supported in part by the Heart and Stroke Foundation of Canada (grants NA3767 and NA4189) and the Medical Research Council of Canada (grant MT13513). V.R., M.A.B., and G.C. are Research Fellows of the Heart and Stroke Foundation of Canada. T.M.Y. is a Research Fellow of the Medical Research Council.

Address for reprints: Richard D. Weisel, MD, Chair, Division of Cardiovascular Surgery, EN 14-215, The Toronto Hospital, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4.

Background: Improved methods of myocardial preservation are required to reduce the morbidity and mortality of coronary bypass surgery for high-risk subgroups. Metabolic stimulation with insulin, glucose solutions, or both has been proposed as a method to preserve the ischemic myocardium. We performed a prospective, double-blind, randomized trial to evaluate the effects of insulin and glucose as cardioplegic additives when used as part of a tepid continuous blood cardioplegic strategy.
Methods: We randomized 56 male patients undergoing elective isolated coronary bypass surgery to 1 of 4 cardioplegic groups containing either 42 or 84 mmol/L glucose with or without 10 IU/L of insulin. Perioperative assessments of myocardial metabolism and left ventricular function were performed.
Results: Insulin-enhanced cardioplegia was associated with beneficial effects on both myocardial metabolic and functional recovery after cardioplegic arrest. Insulin’s effect was independent of the ambient glucose concentration.
Conclusions: Cardioplegic formulations containing a 42 mmol/L concentration of glucose and a 10 IU/L concentration of insulin provide significant benefit to patients undergoing isolated coronary bypass surgery. The clinical effect of these formulations will need to be assessed in high-risk subgroups of patients, such as those with unstable angina, recent myocardial infarction, or poor left ventricular function.

This article has been cited by other articles:

				H. Hwang, J. M. Arcidi Jr, S. L. Hale, B. Z. Simkhovich, L. Belardinelli, A. K. Dhalla, J. C. Shryock, and R. A. Kloner Ranolazine as a Cardioplegia Additive Improves Recovery of Diastolic Function in Isolated Rat Hearts Circulation, September 15, 2009; 120(11_suppl_1): S16 - S21. [Abstract] [Full Text] [PDF]

				G. Y. Gandhi, M. H. Murad, D. N. Flynn, P. J. Erwin, A. B. Cavalcante, H. B. Nielsen, S. E. Capes, K. Thorlund, V. M. Montori, and P. J. Devereaux Effect of Perioperative Insulin Infusion on Surgical Morbidity and Mortality: Systematic Review and Meta-analysis of Randomized Trials Mayo Clin. Proc., April 1, 2008; 83(4): 418 - 430. [Abstract] [Full Text] [PDF]

				T. B. Albacker, G. Carvalho, T. Schricker, and K. Lachapelle Myocardial Protection During Elective Coronary Artery Bypass Grafting Using High-Dose Insulin Therapy Ann. Thorac. Surg., December 1, 2007; 84(6): 1920 - 1927. [Abstract] [Full Text] [PDF]

				G. Li, I. S. Ali, and R. W. Currie Insulin induces myocardial protection and Hsp70 localization to plasma membranes in rat hearts Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1709 - H1721. [Abstract] [Full Text] [PDF]

				J. D. Schipke, R. Friebe, and E. Gams Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials. Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 479 - 485. [Abstract] [Full Text] [PDF]

				D. W. Quinn, D. Pagano, and R. S. Bonser Glucose and Insulin Influences on Heart and Brain in Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2005; 9(2): 173 - 178. [Abstract] [PDF]

				W. Bothe, M. Olschewski, F. Beyersdorf, and T. Doenst Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-Analysis Ann. Thorac. Surg., November 1, 2004; 78(5): 1650 - 1657. [Abstract] [Full Text] [PDF]

				G. Li, R. W. Currie, and I. S. Ali Insulin potentiates expression of myocardial heat shock protein 70 Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 281 - 288. [Abstract] [Full Text] [PDF]

				F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli Myocardial protection in adult cardiac surgery: current options and future challenges Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993. [Abstract] [Full Text] [PDF]

				A. S Wechsler and S. K Brockman Myocardial protection: an expanding or contracting discipline? Perfusion, July 1, 2003; 18(4): 213 - 217. [Abstract] [PDF]

				A. P. Furnary, G. Gao, G. L. Grunkemeier, Y. Wu, K. J. Zerr, S. O. Bookin, H. S. Floten, and A. Starr Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1007 - 1021. [Abstract] [Full Text] [PDF]

				T. Doenst, W. Bothe, and F. Beyersdorf Therapy with insulin in cardiac surgery: controversies and possible solutions Ann. Thorac. Surg., February 1, 2003; 75(2): S721 - 728. [Abstract] [Full Text] [PDF]

				S. Verma, P. W.M. Fedak, R. D. Weisel, J. Butany, V. Rao, A. Maitland, R.-K. Li, B. Dhillon, and T. M. Yau Fundamentals of Reperfusion Injury for the Clinical Cardiologist Circulation, May 21, 2002; 105(20): 2332 - 2336. [Full Text] [PDF]

				V. Rao, G. T. Christakis, R. D. Weisel, J. Ivanov, M. A. Borger, and G. Cohen The Insulin Cardioplegia Trial: Myocardial protection for urgent coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 928 - 935. [Abstract] [Full Text] [PDF]

				M. D. Crittenden Intraoperative metabolic monitoring of the heart: I. Clinical assessment of coronary sinus metabolites Ann. Thorac. Surg., December 1, 2001; 72(6): S2220 - 2226. [Abstract] [Full Text] [PDF]

				T. Doenst, B. E. Ayres, and F. Beyersdorf Insulin cardioplegia for elective coronary bypass surgery J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1221 - 1222. [Full Text] [PDF]

				V. Rao and R. D. Weisel Reply J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1222 - 1222. [Full Text] [PDF]

				M. Hynninen, M. A. Borger, V. Rao, R. D. Weisel, G. T. Christakis, J.-A. Carroll, and D. C. H. Cheng The Effect of Insulin Cardioplegia on Atrial Fibrillation After High-Risk Coronary Bypass Surgery: A Double-Blinded, Randomized, Controlled Trial Anesth. Analg., April 1, 2001; 92(4): 810 - 816. [Abstract] [Full Text] [PDF]